Evaluation of the Efficacy of Systemic Treatments for Alopecia (ESTAA)

Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata

NCT05910138 ·Status: UNKNOWN ·Phase: NA

Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata

NCT02974868 ·Status: COMPLETED ·Phase: PHASE2

Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

NCT06531109 ·Status: RECRUITING

Alefacept in Patients With Severe Scalp Alopecia Areata

NCT00167102 ·Status: COMPLETED ·Phase: NA

A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)

NCT06402630 ·Status: COMPLETED ·Phase: PHASE2

1565nm Non-ablative Fractional Laser Treat Alopecia Areata

NCT05744505 ·Status: UNKNOWN ·Phase: NA

Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata

NCT02684123 ·Status: COMPLETED ·Phase: NA

The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade

NCT02037191 ·Status: COMPLETED ·Phase: PHASE3

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

NCT05098600 ·Status: COMPLETED

Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia

NCT01231607 ·Status: COMPLETED ·Phase: PHASE3

LEO 124249 Ointment in the Treatment of Alopecia Areata

NCT02561585 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

NCT06648850 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia

NCT02014584 ·Status: COMPLETED ·Phase: PHASE3

Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants

NCT05865041 ·Status: RECRUITING ·Phase: PHASE2

Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata

NCT07174011 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata

NCT05556265 ·Status: TERMINATED ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia

NCT06118866 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

NCT06501924 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

PF-06651600 for the Treatment of Alopecia Areata

NCT03732807 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

NCT02812342 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser

NCT06239324 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata

NCT02018042 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata

NCT05470413 ·Status: UNKNOWN ·Phase: PHASE3

A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata

NCT01917058 ·Status: WITHDRAWN ·Phase: PHASE2

Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated Factors

NCT05588310 ·Status: UNKNOWN